In vitro antigen ELISA for quality control of tetanus vaccines.
暂无分享,去创建一个
[1] R. Tierney,et al. Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed. , 2011, Biologicals : journal of the International Association of Biological Standardization.
[2] Marlies Halder,et al. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs. , 2011, Biologicals : journal of the International Association of Biological Standardization.
[3] P. Rigsby,et al. Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed. , 2010, Biologicals : journal of the International Association of Biological Standardization.
[4] R. Tierney,et al. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines. , 2009, Journal of immunological methods.
[5] R. Tierney,et al. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test. , 2008, Biologicals : journal of the International Association of Biological Standardization.
[6] R. G. Das,et al. WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland. , 2008, Vaccine.
[7] V. V. Sviridov,et al. Determination of Tetanus Toxin and Toxoid by ELISA Using Monoclonal Antibodies , 2004, Applied Biochemistry and Microbiology.
[8] R. Jankov,et al. Development of Sandwich Enzyme‐Linked Immunosorbent Assay for Determination of Tetanus Toxoid Concentration , 2004, Journal of immunoassay & immunochemistry.
[9] Bernard Metz,et al. Reduction of animal use in human vaccine quality control: opportunities and problems. , 2002, Vaccine.
[10] G. Kersten,et al. An in vitro approach in quality control of toxoid vaccines. , 2001, Vaccine.
[11] Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine. , 1999, Biologicals : journal of the International Association of Biological Standardization.
[12] C. Jones,et al. Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. , 1996, Vaccine.
[13] D. Sesardic,et al. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. , 1996, Biologicals : journal of the International Association of Biological Standardization.
[14] D. Sesardic,et al. Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. , 1994, Vaccine.
[15] Gary J. Nabel,et al. New Generation Vaccines , 1990 .
[16] A. J. Sheppard,et al. Production and characterization of monoclonal antibodies to tetanus toxin , 1984, Infection and immunity.
[17] J. Lyng,et al. The second international standard for tetanus toxoid (adsorbed). , 1984, Journal of biological standardization.
[18] T. Sundaresan,et al. International collaborative studies on potency assays of diphtheria and tetanus toxoids. , 1972, Bulletin of the World Health Organization.
[19] V. K. Volk,et al. Response to two small doses of tetanus toxoid singly or combined as DT or DTP. , 1963, Public health reports.
[20] L. Levine,et al. Factors affecting the efficiency of the aluminum adjuvant in diphtheria and tetanus toxoids. , 1955, Journal of Immunology.
[21] Factors affecting the efficiency of combined prophylactics. I. Effect of diphtheria toxoid and pertussis vaccine on tetanus toxoid. , 1954, Journal of immunology.